Evaluation of the plasma level of long non‐coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients-Reference-Cited by-同舟云学术

Evaluation of the plasma level of long non‐coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients

Author:

Rezatabar Setareh¹²,Moudi Emadoddin³⁴,Sadeghi Farzin⁵,Khafri Soraya⁶,Kopi Tayebeh Azramezani²,Parsian Hadi⁵^ORCID

Affiliation:

1. Student Research Committee Babol University of Medical Sciences Babol Iran

2. Department of Clinical Biochemistry Babol University of Medical Sciences Babol Iran

3. Department of Urology, Shahid Beheshti Hospital Babol University of Medical Sciences Babol Iran

4. Cancer Research Center, Health Research Institute Babol University of Medical Sciences Babol Iran

5. Cellular and Molecular Biology Research Center, Health Research Institute Babol University of Medical Sciences Babol Iran

6. Department of Epidemiology Babol University of Medical Sciences Babol Iran

Publisher

Wiley

Subject

Genetics(clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Link

Reference25 articles.

2. A case‐control study of risk factors for prostate cancer in Iran;Hosseini M;Acta Med Iran,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Noncoding RNAs in prostate cancer patients;Clinical Applications of Non-Coding RNAs in Cancer;2022